The girl's head is flung back, her mouth open in a cry of pain. She doesn't feel anything. She is a bronze sculpture symbolizing the suffering of 10,000 or more children around the world born in the '50s and '60s who did suffer greatly, and still do, as adults. Because their mothers ingested the notorious drug thalidomide, they were born without legs or arms or with foreshortened limbs like The Sick Child cast in bronze. Some were born deaf and blind; some with curved spines, or with heart and brain damage.
The over-the-counter tranquilizer was hailed as a wonder drug when released in the late 1950s. Its maker, Chemie Grünenthal, a small German company relatively new to pharmacology, marketed it aggressively in 46 countries with the guarantee that it could be "given with complete safety to pregnant women and nursing mothers without any adverse effect on mother and child." During the four years it was on the market, doctors prescribed it as a nontoxic antidote to morning sickness and sleeplessness—and it sold by the millions.
For nearly half a century, the privately owned company was silent and secretive about the epic tragedy it created while earning a vast profit. Even before its release, the wife of an employee gave birth to a baby without ears, but Chemie Grünenthal ignored the warning. Within two years, an estimated million people in West Germany were taking the drug on a daily basis.
But by early 1959, reports started to surface that the drug was toxic, with scores of adults suffering from peripheral neuritis damaging the nervous system. As profits kept rolling in, however, Chemie Grünenthal suppressed that information, bribing doctors and pressuring critics and medical journals for years. Even after an Australian doctor connected thalidomide with deformed births in 1961, it took four months for the company to withdraw the drug. By then, it is estimated to have affected 100,000 pregnant women, causing at least 90,000 miscarriages and thousands of deformities to the babies who survived.
Despite the overwhelming evidence that thalidomide caused miscarriages and birth defects, Chemie Grünenthal for years fought to resist paying the necessary compensation required for a lifetime of care—and still does. Victims say the company's payments have been derisory and far from enough to pay for the expensive care needed by those severely deformed. (more...)
